Kilitch-Drugs-(India)-Ltd Stock/Share Prices, Buy and Sell Kilitch-Drugs-(India)-Ltd BSE Stocks

Market Snapshot

BSE Sensex: 49034.67 -1.11%
BSE 500: 18968.73 -1.13%
BSE 200: 6120.94 -1.14%
BSE 100: 14593.13 -1.14%
BSE Mid-Cap: 18904.14 -1.25%
BSE Small-Cap: 18682.12 -1.06%
BANKEX: 36540.47 -0.99%
BSE IT Sector: 26352.98 -1.93%
Nifty 50: 14433.7 -1.11%
Nifty 500: 11931.2 -1.15%
Nifty 200: 7488 -1.16%
Nifty 100: 14558.8 -1.17%
Nifty Midcap 100: 21934.25 -1.06%
Nifty Small 100: 7401.6 -1.07%
Nifty IT: 26362.8 -2.24%
Nifty PSU Bank: 1937.3 -2.06%

News:

Dixon Tech board to mull stock...
PVR posts Q3 net loss of Rs 49...
Dishman Carbogen Amcis Ltd lea...
Palm Jewels Ltd leads losers i...
GAIL (India) board approves Rs...

Kilitch Drugs (India) Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

15 Jan 2021 | 03:59 PM

95.25

0.05 (0.05%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-27.7%

Return (1Y)

Underperformed S&P BSE Sensex by 44.81%
More Volatile

3.8%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 1.78%
Not so consistent

4/12

Months

underperformed S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

138

News & Announcements

Kilitch Drugs (India) consolidated net profit rises 55.22% in the September 2020 quarter
62 days ago

Kilitch Drugs (India) consolidated net profit rises 55.22% in the September 2020 quarter

14 - Nov - 2020 12:00 AM | 62 days ago

Net profit of Kilitch Drugs (India) rose 55.22% to Rs 2.08 crore in the quarter ended September 2020 as against Rs 1.34 crore during the previous quarter ended September 2019. Sales rose 17.80% to Rs 18.07 crore in the quarter ended September 2020 as against Rs 15.34 crore during the previous quarter ended September 2019.
Particulars Quarter Ended
Sep. 2020 Sep. 2019 % Var.
Sales 18.07 15.34 18
OPM % 16.38 11.15 -
PBDT 3.20 2.13 50
PBT 2.71 1.68 61
NP 2.08 1.34 55
Powered by Capital Market - Live News
Kilitch Drugs (India) to conduct board meeting
69 days ago

Kilitch Drugs (India) to conduct board meeting

07 - Nov - 2020 12:00 AM | 69 days ago

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 13 November 2020.
Powered by Capital Market - Live News
Kilitch Drugs (India) reports consolidated net loss of Rs 1.33 crore in the June 2020 quarter
122 days ago

Kilitch Drugs (India) reports consolidated net loss of Rs 1.33 crore in the June 2020 quarter

16 - Sep - 2020 12:00 AM | 122 days ago

Net Loss of Kilitch Drugs (India) reported to Rs 1.33 crore in the quarter ended June 2020 as against net loss of Rs 0.19 crore during the previous quarter ended June 2019. Sales declined 2.30% to Rs 10.19 crore in the quarter ended June 2020 as against Rs 10.43 crore during the previous quarter ended June 2019.
Particulars Quarter Ended
Jun. 2020 Jun. 2019 % Var.
Sales 10.19 10.43 -2
OPM % -10.89 -7.00 -
PBDT -1.04 0.50 PL
PBT -1.52 0.06 PL
NP -1.33 -0.19 -600
Powered by Capital Market - Live News
Kilitch Drugs (India) to declare Quarterly Result
129 days ago

Kilitch Drugs (India) to declare Quarterly Result

08 - Sep - 2020 12:00 AM | 129 days ago

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 15 September 2020.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Kilitch Drugs (India) Ltd has opened at 99.85 i.e 3.04% above then yesterday's closing price of 96.9

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2020	Sep. 2019	% Var.
Sales	18.07	15.34	18
OPM %	16.38	11.15	-
PBDT	3.20	2.13	50
PBT	2.71	1.68	61
NP	2.08	1.34	55

Particulars	Quarter Ended
	Jun. 2020	Jun. 2019	% Var.
Sales	10.19	10.43	-2
OPM %	-10.89	-7.00	-
PBDT	-1.04	0.50	PL
PBT	-1.52	0.06	PL
NP	-1.33	-0.19	-600

General Notifications

My Notifications

Research Notifications

Kilitch Drugs (India) Ltd NSE / BSE Pharmaceuticals, Small Cap

95.25 0.05 (0.05%)

News & Announcements

Price vs Volume

Stock Trivia

Kilitch Drugs (India) Ltd NSE / BSE
Pharmaceuticals, Small Cap

95.25

0.05 (0.05%)